EARNEST PARTNERS LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
EARNEST PARTNERS LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,223
+10.6%
490.0%0.00%
Q2 2023$2,010
+14.8%
490.0%0.00%
Q1 2023$1,751
-5.4%
490.0%0.00%
Q4 2022$1,851
-7.4%
490.0%0.00%
Q3 2022$2,0000.0%490.0%0.00%
Q2 2022$2,0000.0%490.0%0.00%
Q1 2022$2,000
+100.0%
490.0%0.00%
Q4 2021$1,000
-50.0%
490.0%0.00%
Q3 2021$2,0000.0%490.0%0.00%
Q2 2021$2,0000.0%490.0%0.00%
Q1 2021$2,000
-33.3%
490.0%0.00%
Q4 2020$3,000
+50.0%
490.0%0.00%
Q3 2020$2,000
-33.3%
490.0%0.00%
Q2 2020$3,000
+50.0%
490.0%0.00%
Q1 2020$2,000
-33.3%
490.0%0.00%
Q4 2019$3,0000.0%490.0%0.00%
Q3 2019$3,0000.0%490.0%0.00%
Q2 2019$3,000
-25.0%
490.0%0.00%
Q1 2019$4,000
+33.3%
490.0%0.00%
Q4 2018$3,0000.0%490.0%0.00%
Q3 2018$3,000
+50.0%
490.0%0.00%
Q2 2018$2,0000.0%490.0%0.00%
Q1 2018$2,0000.0%490.0%0.00%
Q4 2017$2,0000.0%490.0%0.00%
Q4 2016$2,000490.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders